Rosalind Advisors »

Viridian Therapeutics shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Viridian Therapeutics shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Viridian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viridian Therapeutics held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viridian Therapeutics by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $53k 264k 0.20

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding Viridian Therapeutics

Rosalind Advisors
Group One Trading
Simplex Trading

View all funds holding Viridian Therapeutics